APOBEC3B and invasive breast carcinoma: Consistent with the anti-mutagenic activity of PrimPol in prohibiting transversions at AID-induced AP-sites in germinal centre B cells, mutation spectra in human invasive breast cancers strongly suggest that this activity also applies to APOBEC3B-induced AP-sites and likely all AP-sites generated during Base Excision Repair.